Figure 1
From: Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya
Study design and volunteer recruitment. 118 participants were excluded following screening. For reasons see Figure 2. In each group, the total dose of sporozoites was split between two injection sites and administered as two 50 μL injections, one in each deltoid.